Free Trial
→ 379 passengers walked away from this (From True Market Insiders) (Ad) Buy PLPC Stock  Free PLPC Stock Alerts

Preformed Line Products (PLPC) Financials

Preformed Line Products logo
$153.54 -1.94 (-1.25%)
Closing price 04:00 PM Eastern
Extended Trading
$153.66 +0.13 (+0.08%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Preformed Line Products

Annual Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 13 6.68 15 13 27 23 30 36 54 63 37
Consolidated Net Income / (Loss)		 13 6.68 15 13 27 23 30 36 54 63 37
Net Income / (Loss) Continuing Operations		 13 6.68 15 13 27 23 30 36 54 63 37
Total Pre-Tax Income 		21 12 21 26 33 31 41 49 74 82 51
Total Operating Income		 21 12 21 26 33 33 40 48 69 84 51
Total Gross Profit		 121 103 109 119 132 141 154 166 215 235 190
Total Revenue		 388 355 337 378 421 445 466 517 637 670 594
Operating Revenue		 388 355 337 378 421 445 466 517 637 670 594
Total Cost of Revenue		 267 251 227 260 289 304 312 351 422 435 404
Operating Cost of Revenue		 267 251 227 260 289 304 312 351 422 435 404
Total Operating Expenses		 100 91 88 93 99 108 114 119 146 151 139
Selling, General & Admin Expense		 43 37 42 43 45 52 56 55 70 75 67
Marketing Expense		 36 31 32 34 36 37 36 41 46 51 49
Research & Development Expense		 16 15 14 14 15 17 18 19 20 22 22
Other Operating Expenses / (Income)		 5.19 8.75 0.05 0.99 2.43 2.37 4.21 3.71 3.60 2.49 0.93
Impairment Charge		 - - - - - - 0.00 0.00 6.53 0.00 0.00
Total Other Income / (Expense), net		 0.17 -0.64 -0.53 -0.30 -0.35 -1.17 0.36 1.35 4.34 -1.81 0.01
Interest Expense		 0.66 0.57 0.84 1.06 1.29 2.22 2.40 2.02 3.21 3.91 2.22
Interest & Investment Income		 0.48 0.39 0.29 0.43 0.49 0.78 0.26 0.17 0.63 1.81 2.57
Other Income / (Expense), net		 0.35 -0.47 0.03 0.33 0.46 0.27 2.50 3.20 6.93 0.28 -0.34
Income Tax Expense		 8.55 5.03 5.70 13 6.01 8.12 11 13 19 19 14
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - 0.00 0.00 0.03 -0.04 -0.01 0.00 0.01 0.02
Basic Earnings per Share		 $2.39 $1.25 $2.95 $2.48 - $4.63 $6.05 $7.28 $11.03 $12.87 $7.56
Weighted Average Basic Shares Outstanding		 5.38M 5.35M 5.17M 5.10M 5.03M 5.03M 4.92M 4.91M 4.93M 4.92M 4.91M
Diluted Earnings per Share		 $2.39 $1.24 $2.95 $2.47 - $4.58 $5.98 $7.19 $10.88 $12.68 $7.50
Weighted Average Diluted Shares Outstanding		 5.38M 5.37M 5.18M 5.13M 5.11M 5.09M 4.98M 4.97M 5.00M 5.00M 4.95M
Weighted Average Basic & Diluted Shares Outstanding		 5.40M 5.30M 5.20M 5.10M 5M 5.02M 4.93M 4.91M 4.92M 4.90M 4.94M
Cash Dividends to Common per Share		 $0.80 $0.80 $0.80 $0.80 $0.80 - - - $0.80 $0.80 $0.80

Quarterly Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 12 17 21 20 15 6.33 9.60 9.37 7.68 10 12
Consolidated Net Income / (Loss)		 12 16 21 20 15 6.31 9.60 9.37 7.70 10 12
Net Income / (Loss) Continuing Operations		 12 16 21 20 15 6.31 9.60 9.37 7.70 10 12
Total Pre-Tax Income 		18 24 28 28 20 6.97 12 11 10 17 14
Total Operating Income		 17 25 29 28 20 6.95 12 11 10 18 13
Total Gross Profit		 58 62 66 66 54 48 44 44 46 56 49
Total Revenue		 165 170 182 182 160 146 141 139 147 167 149
Operating Revenue		 165 170 182 182 160 146 141 139 147 167 149
Total Cost of Revenue		 107 108 116 115 106 98 97 94 101 111 100
Operating Cost of Revenue		 107 108 116 115 106 98 97 94 101 111 100
Total Operating Expenses		 41 38 37 38 34 41 33 33 35 38 36
Selling, General & Admin Expense		 17 20 19 18 18 20 17 15 16 19 18
Marketing Expense		 11 12 12 13 13 13 12 12 12 13 12
Research & Development Expense		 4.74 4.78 5.19 5.76 5.84 5.69 5.43 5.36 5.55 5.59 5.48
Other Operating Expenses / (Income)		 0.94 1.13 1.11 1.19 -2.31 2.50 -1.37 0.45 1.11 0.75 0.26
Total Other Income / (Expense), net		 0.22 -0.38 -0.72 -0.61 -0.50 0.02 0.30 -0.13 0.04 -0.19 0.54
Interest Expense		 0.82 1.09 1.07 1.13 1.00 0.71 0.71 0.57 0.56 0.38 0.38
Interest & Investment Income		 0.14 0.27 0.30 0.42 0.48 0.61 0.97 0.35 0.54 0.72 0.51
Other Income / (Expense), net		 0.90 0.43 0.04 0.11 0.02 0.12 0.04 0.09 0.06 -0.53 0.41
Income Tax Expense		 5.71 7.72 6.84 7.08 4.43 0.66 2.26 1.79 2.73 6.88 2.12
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 -0.02 0.02 -0.01 0.02 -0.02 0.01 0.00 0.02 -0.01 0.04
Basic Earnings per Share		 $2.41 $3.35 $4.33 $4.14 $3.08 $1.32 $1.95 $1.91 $1.57 $2.13 $2.34
Weighted Average Basic Shares Outstanding		 4.94M 4.93M 4.94M 4.94M 4.91M 4.92M 4.92M 4.92M 4.90M 4.91M 4.93M
Diluted Earnings per Share		 $2.36 $3.26 $4.28 $4.08 $3.03 $1.29 $1.94 $1.89 $1.54 $2.13 $2.33
Weighted Average Diluted Shares Outstanding		 5.04M 5.00M 5.00M 5.02M 4.99M 5.00M 4.94M 4.96M 4.98M 4.95M 4.95M
Weighted Average Basic & Diluted Shares Outstanding		 4.92M 4.92M 4.95M 4.92M 4.89M 4.90M 4.92M 4.91M 4.90M 4.94M 4.94M
Cash Dividends to Common per Share		 - - - - $0.20 - $0.20 - $0.20 - $0.20

Annual Cash Flow Statements for Preformed Line Products

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 5.35 0.75 0.35 12 -0.10 -4.65 5.91 -8.77 0.83 16 3.64
Net Cash From Operating Activities		 25 20 26 34 23 27 42 34 26 108 67
Net Cash From Continuing Operating Activities		 25 20 26 34 23 27 42 34 26 108 67
Net Income / (Loss) Continuing Operations		 13 6.68 15 13 27 23 30 36 54 63 37
Consolidated Net Income / (Loss)		 13 6.68 15 13 27 23 30 36 54 63 37
Depreciation Expense		 13 12 12 13 12 14 14 16 16 19 21
Non-Cash Adjustments To Reconcile Net Income		 5.04 4.14 6.81 5.80 7.88 8.11 9.29 11 12 14 6.12
Changes in Operating Assets and Liabilities, net		 -5.50 -2.11 -8.08 2.59 -24 -18 -11 -28 -56 11 3.42
Net Cash From Investing Activities		 -33 -11 -28 -2.56 -14 -49 -14 -18 -47 -45 -12
Net Cash From Continuing Investing Activities		 -33 -11 -28 -2.56 -14 -49 -14 -18 -47 -45 -12
Purchase of Property, Plant & Equipment		 -18 -11 -25 -11 -9.53 -29 -25 -18 -41 -35 -15
Acquisitions		 -15 0.00 - 0.00 0.00 -19 0.00 0.00 -16 -12 0.00
Purchase of Investments		 - - 0.00 0.00 -4.69 -0.50 - - 0.00 0.00 -3.15
Sale of Property, Plant & Equipment		 0.14 0.93 0.07 0.14 0.20 0.05 11 0.14 3.17 2.63 3.45
Sale and/or Maturity of Investments		 - - 0.00 0.00 2.95 2.31 - - 0.00 0.00 1.99
Other Investing Activities, net		 -0.80 -1.04 -3.82 8.53 -2.95 -2.31 0.00 0.00 6.91 0.00 0.00
Net Cash From Financing Activities		 13 -13 4.39 -20 -9.05 18 -23 -23 23 -49 -48
Net Cash From Continuing Financing Activities		 13 -13 4.39 -20 -9.05 18 -23 -23 23 -49 -48
Repayment of Debt		 -57 -53 -58 -65 -85 -64 -110 -114 -154 -197 -132
Repurchase of Common Equity		 -2.23 -7.55 -5.07 -8.48 -4.17 -6.83 -9.46 -5.27 -5.47 -19 -8.61
Payment of Dividends		 -4.41 -4.39 -4.17 -4.10 -4.09 -4.23 -4.18 -4.13 -4.10 -4.11 -4.08
Issuance of Debt		 77 52 71 56 84 93 100 99 185 169 96
Issuance of Common Equity		 0.17 0.08 0.25 1.96 0.22 0.21 0.25 0.41 0.81 2.16 0.21
Other Net Changes in Cash		 - - -1.54 - - -0.78 - -0.89 -1.11 2.44 -3.68

Quarterly Cash Flow Statements for Preformed Line Products

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 0.85 6.29 -5.45 11 0.58 9.87 -7.75 1.57 0.07 9.75 -2.41
Net Cash From Operating Activities		 15 17 25 20 43 19 5.75 28 9.37 24 5.66
Net Cash From Continuing Operating Activities		 15 17 25 20 43 19 5.75 28 9.37 24 5.66
Net Income / (Loss) Continuing Operations		 12 16 21 20 15 6.31 9.60 9.37 7.70 10 12
Consolidated Net Income / (Loss)		 12 16 21 20 15 6.31 9.60 9.37 7.70 10 12
Depreciation Expense		 3.31 6.24 4.28 4.69 4.64 5.31 5.41 5.25 5.32 4.85 5.40
Non-Cash Adjustments To Reconcile Net Income		 7.40 5.66 3.02 3.91 0.92 6.58 -0.23 0.16 1.08 5.11 0.63
Changes in Operating Assets and Liabilities, net		 -7.30 -11 -3.29 -8.64 22 1.09 -9.03 14 -4.73 3.67 -12
Net Cash From Investing Activities		 -11 -19 -22 -6.84 -7.56 -8.09 -0.68 -3.60 -3.45 -4.63 -9.66
Net Cash From Continuing Investing Activities		 -11 -19 -22 -6.84 -7.56 -8.09 -0.68 -3.60 -3.45 -4.63 -9.66
Purchase of Property, Plant & Equipment		 -11 -15 -8.35 -8.83 -9.94 -8.21 -3.92 -3.73 -3.57 -3.43 -11
Purchase of Investments		 - - - - - - 0.00 - - - -0.45
Sale of Property, Plant & Equipment		 - 0.01 0.12 0.01 2.38 0.13 3.24 0.13 0.13 -0.04 0.09
Sale and/or Maturity of Investments		 - - - - - - 0.00 - - - 1.68
Net Cash From Financing Activities		 -0.88 7.90 -9.31 -2.36 -34 -3.38 -12 -22 -7.30 -7.00 -0.02
Net Cash From Continuing Financing Activities		 -0.88 7.90 -9.31 -2.36 -34 -3.38 -12 -22 -7.30 -7.00 -0.02
Repayment of Debt		 -41 -48 -55 -49 -46 -46 -38 -45 -45 -8.11 -2.74
Repurchase of Common Equity		 -2.14 -1.53 -3.74 -6.10 -8.56 -0.49 -5.45 -0.57 -2.23 -0.35 -4.81
Payment of Dividends		 -1.02 -1.01 -1.15 -0.99 -0.98 -0.98 -1.13 -0.98 -0.98 -0.98 -1.16
Issuance of Debt		 43 58 50 54 21 44 33 25 41 2.39 8.63
Issuance of Common Equity		 0.36 0.33 0.36 0.31 1.36 0.14 0.06 0.00 0.10 0.05 0.07
Effect of Exchange Rate Changes		 - - 0.72 0.15 -0.48 - - - - - 1.62

Annual Balance Sheets for Preformed Line Products

This table presents Preformed Line Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 354 323 341 360 359 434 461 489 568 603 574
Total Current Assets		 201 180 189 207 214 232 256 272 328 325 316
Restricted Cash		 - - - - - - 45 36 37 54 57
Accounts Receivable		 68 64 63 74 73 84 93 98 125 107 111
Inventories, net		 80 70 74 78 85 96 98 115 147 149 130
Prepaid Expenses		 6.93 4.03 3.35 3.43 6.21 6.92 18 20 13 8.25 12
Other Current Assets		 6.63 6.34 8.44 2.21 2.88 4.29 3.26 3.22 4.93 7.26 5.51
Plant, Property, & Equipment, net		 103 92 105 109 103 124 126 150 175 208 195
Total Noncurrent Assets		 51 52 47 44 42 78 79 67 65 70 63
Goodwill		 18 16 16 17 16 28 30 28 28 29 27
Intangible Assets		 14 11 10 10 8.46 15 14 12 14 13 9.66
Noncurrent Deferred & Refundable Income Taxes		 5.77 13 10 7.77 6.90 7.56 11 3.84 5.32 7.11 6.55
Other Noncurrent Operating Assets		 13 12 10 9.72 11 27 24 23 18 21 20
Total Liabilities & Shareholders' Equity		 354 323 341 360 359 434 461 489 568 603 574
Total Liabilities		 111 104 117 121 109 165 169 173 210 187 152
Total Current Liabilities		 55 52 55 63 69 81 104 106 115 111 108
Short-Term Debt		 1.93 0.52 2.76 2.31 10 12 23 20 21 13 10
Accounts Payable		 22 20 22 25 26 28 32 42 47 38 42
Accrued Expenses		 15 13 12 15 13 17 18 18 18 27 26
Dividends Payable		 1.22 1.06 1.04 1.05 1.05 1.17 1.29 1.30 1.32 1.30 1.29
Current Deferred & Payable Income Tax Liabilities		 - 1.42 1.06 1.90 0.82 1.76 5.46 1.11 2.47 1.67 1.96
Current Employee Benefit Liabilities		 15 15 16 18 18 19 23 22 24 28 26
Other Current Liabilities		 - - - - 0.00 2.06 2.24 1.99 1.61 1.67 1.59
Total Noncurrent Liabilities		 56 53 62 58 40 84 65 67 95 76 43
Long-Term Debt		 32 32 43 35 25 54 33 40 68 49 18
Noncurrent Deferred & Payable Income Tax Liabilities		 5.02 2.47 2.08 2.09 1.71 3.12 2.92 2.79 4.17 3.54 3.77
Other Noncurrent Operating Liabilities		 6.45 6.87 6.50 11 8.01 22 23 21 22 23 21
Total Equity & Noncontrolling Interests		 243 219 224 239 249 269 292 316 359 416 422
Total Preferred & Common Equity		 243 219 224 239 249 269 292 316 359 416 422
Total Common Equity		 243 219 224 239 249 269 292 316 359 416 422
Common Stock		 35 35 37 42 47 52 56 61 67 75 79
Retained Earnings		 290 292 303 312 334 353 379 411 461 520 553
Treasury Stock		 -47 -55 -60 -68 -72 -79 -89 -94 -99 -118 -127
Accumulated Other Comprehensive Income / (Loss)		 -35 -54 -57 -47 -60 -57 -55 -62 -70 -60 -83
Other Equity Adjustments		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest		 - - - - 0.00 0.03 -0.01 -0.02 -0.01 -0.01 0.01

Quarterly Balance Sheets for Preformed Line Products

This table presents Preformed Line Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 537 531 602 622 607 586 573 592 592
Total Current Assets		 307 308 339 353 338 314 305 321 327
Restricted Cash		 - - 32 43 44 46 - 47 55
Accounts Receivable		 123 123 141 145 126 112 101 111 119
Inventories, net		 127 135 150 148 150 142 142 143 135
Prepaid Expenses		 - - 8.30 8.75 8.33 8.31 7.39 13 12
Other Current Assets		 5.56 3.25 8.18 8.44 10 7.05 6.98 6.48 6.02
Plant, Property, & Equipment, net		 157 160 196 200 201 203 200 201 203
Total Noncurrent Assets		 73 63 67 68 67 69 67 70 63
Goodwill		 35 26 29 30 28 29 28 29 28
Intangible Assets		 15 14 14 14 13 12 11 11 9.74
Noncurrent Deferred & Refundable Income Taxes		 5.55 5.90 6.15 6.42 6.93 7.38 7.72 9.50 6.28
Other Noncurrent Operating Assets		 17 17 17 18 19 21 20 21 19
Total Liabilities & Shareholders' Equity		 537 531 602 622 607 586 573 592 592
Total Liabilities		 204 200 222 223 207 173 156 163 157
Total Current Liabilities		 120 120 125 127 136 100 104 114 106
Short-Term Debt		 20 21 17 21 18 8.57 9.75 11 9.22
Accounts Payable		 49 48 56 50 51 42 43 42 45
Accrued Expenses		 22 18 19 23 27 21 23 26 27
Dividends Payable		 1.24 1.28 1.19 1.23 1.26 1.19 1.22 1.26 1.15
Current Deferred & Payable Income Tax Liabilities		 0.56 2.36 7.80 5.79 6.76 2.36 1.53 2.35 1.15
Current Employee Benefit Liabilities		 24 28 22 25 30 23 24 29 21
Other Current Liabilities		 1.96 1.64 1.54 1.19 1.63 1.53 1.56 1.61 1.75
Total Noncurrent Liabilities		 85 79 96 97 71 73 52 49 51
Long-Term Debt		 58 56 68 69 45 48 29 25 26
Capital Lease Obligations		 - 6.33 7.11 - 7.91 7.39 - 6.99 6.46
Noncurrent Deferred & Payable Income Tax Liabilities		 4.25 3.86 3.51 3.31 2.98 3.41 2.21 2.84 3.02
Other Noncurrent Operating Liabilities		 20 13 17 24 15 14 21 15 16
Total Equity & Noncontrolling Interests		 333 331 381 398 400 413 416 429 436
Total Preferred & Common Equity		 333 331 381 398 400 413 416 429 436
Total Common Equity		 333 331 381 398 400 413 416 429 436
Common Stock		 63 65 68 70 73 75 76 77 76
Retained Earnings		 435 445 481 501 515 529 537 544 564
Treasury Stock		 -96 -98 -103 -109 -118 -124 -124 -127 -128
Accumulated Other Comprehensive Income / (Loss)		 -70 -82 -66 -64 -70 -67 -73 -65 -76
Other Equity Adjustments		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest		 0.01 0.01 0.01 0.00 0.02 -0.00 0.00 0.02 0.05

Annual Metrics And Ratios for Preformed Line Products

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.27% -8.63% -5.08% 12.35% 11.28% 5.70% 4.85% 10.93% 23.12% 5.13% -11.34%
EBITDA Growth		 -21.21% -32.02% 43.10% 17.09% 16.85% 1.75% 21.24% 17.27% 39.82% 11.47% -31.06%
EBIT Growth		 -31.75% -44.96% 81.03% 22.93% 26.31% -1.50% 29.84% 18.83% 50.32% 10.68% -40.29%
NOPAT Growth		 -36.75% -44.80% 122.08% -18.13% 109.83% -9.90% 21.86% 17.78% 47.37% 26.44% -42.68%
Net Income Growth		 -37.53% -48.10% 128.54% -17.05% 110.06% -12.21% 27.53% 20.03% 52.29% 16.43% -41.41%
EPS Growth		 -36.60% -48.12% 137.90% -16.27% 0.00% 0.00% 30.57% 20.23% 51.32% 16.54% -40.85%
Operating Cash Flow Growth		 17.26% -19.90% 28.40% 30.25% -32.08% 18.46% 53.00% -19.32% -22.16% 311.59% -37.31%
Free Cash Flow Firm Growth		 1,483.98% 312.41% -105.97% 1,117.91% -17.21% -279.96% 172.76% -107.68% -1,116.58% 348.59% 34.18%
Invested Capital Growth		 1.92% -10.58% 7.94% -3.10% 4.36% 22.42% 2.56% 11.97% 21.04% 3.36% -7.31%
Revenue Q/Q Growth		 -0.61% -1.18% -1.62% 2.84% 2.07% 1.89% 1.05% 2.57% 6.43% -3.50% 3.76%
EBITDA Q/Q Growth		 -2.96% 0.01% 9.44% 2.47% -0.69% 1.10% -5.57% 15.85% 17.54% -15.45% 15.30%
EBIT Q/Q Growth		 -5.35% 7.58% 9.89% 2.54% 0.65% -0.75% -6.95% 18.23% 19.78% -17.53% 24.50%
NOPAT Q/Q Growth		 -4.67% 9.65% 15.85% -25.94% 20.37% 2.88% -11.52% 21.44% 20.47% -13.87% 13.15%
Net Income Q/Q Growth		 -4.77% 9.10% 15.57% -25.79% 20.72% 1.47% -34.82% 116.82% 16.09% -13.85% 12.54%
EPS Q/Q Growth		 -4.02% 8.77% 16.60% -25.83% 0.00% 0.00% -8.70% 21.04% 15.62% -13.45% 12.61%
Operating Cash Flow Q/Q Growth		 -10.08% 67.96% -22.22% 26.94% 19.64% -25.55% 3.83% 4.44% 40.35% 2.14% 7.62%
Free Cash Flow Firm Q/Q Growth		 195.83% -10.75% -606.75% 21.82% 35.55% -284.94% 159.58% -237.42% -182.29% 60.18% 89.88%
Invested Capital Q/Q Growth		 -3.98% -2.48% -0.47% -3.83% -3.61% 4.91% -1.11% 1.68% 7.16% -0.47% -7.06%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 31.16% 29.17% 32.50% 31.37% 31.42% 31.60% 33.02% 32.13% 33.78% 35.07% 31.97%
EBITDA Margin		 8.87% 6.60% 9.95% 10.37% 10.89% 10.48% 12.12% 12.82% 14.55% 15.43% 12.00%
Operating Margin		 5.47% 3.48% 6.38% 6.90% 7.83% 7.33% 8.62% 9.19% 10.89% 12.57% 8.55%
EBIT Margin		 5.56% 3.35% 6.39% 6.99% 7.93% 7.39% 9.16% 9.81% 11.98% 12.61% 8.49%
Profit (Net Income) Margin		 3.31% 1.88% 4.53% 3.35% 6.32% 5.25% 6.38% 6.90% 8.54% 9.46% 6.25%
Tax Burden Percent		 60.07% 57.02% 72.81% 49.04% 81.57% 74.18% 73.36% 73.06% 73.81% 76.92% 73.10%
Interest Burden Percent		 99.19% 98.54% 97.43% 97.61% 97.59% 95.64% 95.00% 96.35% 96.61% 97.52% 100.70%
Effective Tax Rate		 39.93% 42.98% 27.19% 50.96% 18.43% 25.82% 26.64% 26.94% 26.19% 23.08% 26.90%
Return on Invested Capital (ROIC)		 5.19% 3.00% 6.78% 5.43% 11.33% 8.98% 9.82% 10.78% 13.60% 15.44% 9.04%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.57% -5.96% 2.74% 2.34% 15.50% 0.69% 11.15% 16.16% 21.81% 11.06% 8.93%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.11% 0.12% 0.05% -0.43% 0.03% 0.80% 0.97% 2.52% 0.91% -0.19%
Return on Equity (ROE)		 5.19% 2.89% 6.89% 5.48% 10.90% 9.01% 10.62% 11.75% 16.12% 16.35% 8.85%
Cash Return on Invested Capital (CROIC)		 3.28% 14.16% -0.86% 8.57% 7.06% -11.18% 7.30% -0.52% -5.44% 12.14% 16.63%
Operating Return on Assets (OROA)		 6.29% 3.51% 6.47% 7.55% 9.29% 8.30% 9.55% 10.68% 14.43% 14.41% 8.57%
Return on Assets (ROA)		 3.75% 1.97% 4.59% 3.61% 7.40% 5.89% 6.65% 7.52% 10.29% 10.81% 6.31%
Return on Common Equity (ROCE)		 5.19% 2.89% 6.89% 5.48% 10.90% 9.01% 10.62% 11.75% 16.13% 16.35% 8.85%
Return on Equity Simple (ROE_SIMPLE)		 5.29% 3.05% 6.82% 5.30% 10.66% 8.69% 10.19% 11.30% 15.17% 15.22% 8.79%
Net Operating Profit after Tax (NOPAT)		 13 7.04 16 13 27 24 29 35 51 65 37
NOPAT Margin		 3.29% 1.99% 4.65% 3.38% 6.38% 5.44% 6.32% 6.71% 8.04% 9.67% 6.25%
Net Nonoperating Expense Percent (NNEP)		 5.76% 8.95% 4.04% 3.08% -4.18% 8.30% -1.33% -5.38% -8.21% 4.38% 0.11%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 11.42% 13.53% 8.23%
Cost of Revenue to Revenue		 68.84% 70.83% 67.50% 68.63% 68.58% 68.40% 66.98% 67.87% 66.22% 64.93% 68.03%
SG&A Expenses to Revenue		 10.96% 10.40% 12.49% 11.41% 10.79% 11.65% 12.08% 10.68% 11.04% 11.15% 11.37%
R&D to Revenue		 4.20% 4.20% 4.17% 3.79% 3.59% 3.86% 3.78% 3.71% 3.09% 3.36% 3.69%
Operating Expenses to Revenue		 25.69% 25.69% 26.12% 24.46% 23.59% 24.27% 24.40% 22.94% 22.89% 22.50% 23.42%
Earnings before Interest and Taxes (EBIT)		 22 12 22 26 33 33 43 51 76 84 50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 34 23 34 39 46 47 57 66 93 103 71
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.06 0.91 1.22 1.41 1.02 1.07 1.11 0.98 1.13 1.56 1.48
Price to Tangible Book Value (P/TBV)		 1.22 1.04 1.38 1.59 1.13 1.28 1.31 1.13 1.28 1.74 1.62
Price to Revenue (P/Rev)		 0.66 0.56 0.81 0.89 0.61 0.65 0.70 0.60 0.63 0.97 1.05
Price to Earnings (P/E)		 20.04 29.90 17.87 26.55 9.61 12.37 10.93 8.69 7.43 10.26 16.85
Dividend Yield		 1.66% 2.11% 1.50% 1.21% 1.57% 1.39% 1.21% 1.26% 0.97% 0.60% 0.63%
Earnings Yield		 4.99% 3.35% 5.60% 3.77% 10.40% 8.09% 9.15% 11.50% 13.47% 9.74% 5.94%
Enterprise Value to Invested Capital (EV/IC)		 1.06 0.91 1.20 1.42 1.02 1.06 1.11 0.98 1.11 1.55 1.51
Enterprise Value to Revenue (EV/Rev)		 0.67 0.57 0.85 0.87 0.59 0.71 0.72 0.65 0.72 0.98 1.00
Enterprise Value to EBITDA (EV/EBITDA)		 7.60 8.60 8.58 8.37 5.40 6.76 5.95 5.03 4.92 6.37 8.37
Enterprise Value to EBIT (EV/EBIT)		 12.13 16.96 13.37 12.43 7.41 9.58 7.88 6.58 5.98 7.80 11.83
Enterprise Value to NOPAT (EV/NOPAT)		 20.52 28.61 18.39 25.66 9.21 13.02 11.41 9.61 8.91 10.17 16.07
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.37 9.96 11.07 9.71 10.77 11.58 8.08 9.93 17.44 6.12 8.84
Enterprise Value to Free Cash Flow (EV/FCFF)		 32.43 6.05 0.00 16.25 14.78 0.00 15.35 0.00 0.00 12.95 8.73
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.14 0.15 0.20 0.15 0.14 0.24 0.19 0.19 0.25 0.15 0.07
Long-Term Debt to Equity		 0.13 0.15 0.19 0.15 0.10 0.20 0.11 0.13 0.19 0.12 0.04
Financial Leverage		 -0.01 0.02 0.04 0.02 -0.03 0.04 0.07 0.06 0.12 0.08 -0.02
Leverage Ratio		 1.39 1.47 1.50 1.52 1.47 1.53 1.60 1.56 1.57 1.51 1.40
Compound Leverage Factor		 1.37 1.44 1.46 1.48 1.44 1.46 1.52 1.51 1.51 1.47 1.41
Debt to Total Capital		 12.17% 12.85% 16.98% 13.40% 12.45% 19.67% 16.08% 15.86% 19.98% 13.01% 6.34%
Short-Term Debt to Total Capital		 0.70% 0.21% 1.03% 0.84% 3.68% 3.60% 6.51% 5.20% 4.71% 2.81% 2.26%
Long-Term Debt to Total Capital		 11.48% 12.64% 15.95% 12.56% 8.76% 16.07% 9.58% 10.66% 15.27% 10.20% 4.07%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 87.83% 87.15% 83.02% 86.60% 87.55% 80.32% 83.92% 84.14% 80.02% 86.99% 93.66%
Debt to EBITDA		 0.98 1.38 1.36 0.94 0.77 1.41 0.99 0.90 0.97 0.60 0.40
Net Debt to EBITDA		 0.12 0.08 0.45 -0.19 -0.18 0.58 0.19 0.35 0.56 0.08 -0.40
Long-Term Debt to EBITDA		 0.92 1.36 1.28 0.88 0.54 1.15 0.59 0.60 0.74 0.47 0.26
Debt to NOPAT		 2.64 4.58 2.92 2.88 1.32 2.72 1.90 1.72 1.75 0.96 0.77
Net Debt to NOPAT		 0.32 0.27 0.96 -0.58 -0.30 1.11 0.37 0.67 1.02 0.13 -0.77
Long-Term Debt to NOPAT		 2.49 4.51 2.75 2.70 0.93 2.22 1.13 1.15 1.34 0.75 0.49
Altman Z-Score		 4.33 4.11 4.30 4.65 4.67 3.88 4.02 4.06 4.30 5.29 5.58
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.63 3.48 3.41 3.30 3.08 2.86 2.47 2.58 2.85 2.92 2.91
Quick Ratio		 1.76 1.82 1.70 1.88 1.68 1.51 0.89 0.93 1.09 0.96 1.03
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 8.07 33 -1.99 20 17 -30 22 -1.68 -20 51 68
Operating Cash Flow to CapEx		 144.15% 205.89% 105.35% 305.02% 246.18% 92.53% 296.51% 184.17% 69.87% 329.17% 602.66%
Free Cash Flow to Firm to Interest Expense		 12.27 58.93 -2.35 19.05 12.97 -13.59 9.15 -0.83 -6.37 13.03 30.73
Operating Cash Flow to Interest Expense		 38.38 35.80 30.77 31.89 17.81 12.28 17.38 16.61 8.14 27.57 30.38
Operating Cash Flow Less CapEx to Interest Expense		 11.76 18.41 1.56 21.43 10.58 -0.99 11.52 7.59 -3.51 19.19 25.34
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.13 1.05 1.01 1.08 1.17 1.12 1.04 1.09 1.20 1.14 1.01
Accounts Receivable Turnover		 5.73 5.39 5.30 5.51 5.72 5.68 5.29 5.42 5.70 5.77 5.44
Inventory Turnover		 3.47 3.35 3.15 3.41 3.54 3.36 3.23 3.31 3.22 2.94 2.90
Fixed Asset Turnover		 3.82 3.65 3.42 3.54 3.98 3.92 3.73 3.75 3.92 3.50 2.95
Accounts Payable Turnover		 12.12 11.76 10.73 11.02 11.20 11.13 10.43 9.49 9.46 10.28 10.13
Days Sales Outstanding (DSO)		 63.72 67.70 68.87 66.29 63.79 64.27 68.94 67.33 64.02 63.27 67.10
Days Inventory Outstanding (DIO)		 105.08 108.93 115.98 107.12 103.15 108.55 112.88 110.20 113.33 124.35 125.94
Days Payable Outstanding (DPO)		 30.10 31.03 34.02 33.13 32.60 32.81 35.01 38.47 38.60 35.52 36.03
Cash Conversion Cycle (CCC)		 138.69 145.61 150.83 140.29 134.34 140.01 146.82 139.06 138.76 152.09 157.01
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 248 222 240 232 242 297 304 341 412 426 395
Invested Capital Turnover		 1.58 1.51 1.46 1.60 1.77 1.65 1.55 1.61 1.69 1.60 1.45
Increase / (Decrease) in Invested Capital		 4.69 -26 18 -7.41 10 54 7.58 36 72 14 -31
Enterprise Value (EV)		 262 201 288 329 247 315 336 334 456 659 596
Market Capitalization		 258 200 273 336 256 288 326 311 404 650 625
Book Value per Share		 $45.37 $41.54 $43.66 $46.85 $49.75 $53.62 $59.43 $64.51 $72.90 $85.04 $86.23
Tangible Book Value per Share		 $39.41 $36.39 $38.53 $41.63 $44.95 $45.04 $50.49 $56.30 $64.34 $76.36 $78.81
Total Capital		 277 251 269 275 285 334 348 376 448 478 451
Total Debt		 34 32 46 37 35 66 56 60 90 62 29
Total Long-Term Debt		 32 32 43 35 25 54 33 40 68 49 18
Net Debt		 4.03 1.88 15 -7.45 -8.16 27 11 23 52 8.64 -29
Capital Expenditures (CapEx)		 18 9.83 25 11 9.33 29 14 18 37 33 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 118 98 106 102 112 124 130 150 197 173 160
Debt-free Net Working Capital (DFNWC)		 147 129 136 147 155 163 175 186 234 227 218
Net Working Capital (NWC)		 145 128 134 144 145 151 153 167 213 213 207
Net Nonoperating Expense (NNE)		 -0.10 0.37 0.38 0.15 0.28 0.87 -0.27 -0.98 -3.21 1.39 -0.01
Net Nonoperating Obligations (NNO)		 5.25 2.94 16 -6.40 -7.11 28 12 24 54 9.94 -27
Total Depreciation and Amortization (D&A)		 13 12 12 13 12 14 14 16 16 19 21
Debt-free, Cash-free Net Working Capital to Revenue		 30.30% 27.73% 31.39% 27.04% 26.53% 27.88% 27.87% 28.93% 30.88% 25.88% 27.01%
Debt-free Net Working Capital to Revenue		 37.94% 36.30% 40.52% 38.76% 36.89% 36.63% 37.56% 35.97% 36.73% 33.89% 36.65%
Net Working Capital to Revenue		 37.44% 36.15% 39.70% 38.15% 34.40% 33.92% 32.70% 32.19% 33.41% 31.88% 34.93%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.39 $1.25 $2.95 $2.48 $5.28 $4.63 $0.00 $7.28 $11.03 $12.87 $7.56
Adjusted Weighted Average Basic Shares Outstanding		 5.38M 5.35M 5.17M 5.10M 5.03M 5.03M 4.92M 4.91M 4.93M 4.92M 4.91M
Adjusted Diluted Earnings per Share		 $2.39 $1.24 $2.95 $2.47 $5.21 $4.58 $0.00 $7.19 $10.88 $12.68 $7.50
Adjusted Weighted Average Diluted Shares Outstanding		 5.38M 5.37M 5.18M 5.13M 5.11M 5.09M 4.98M 4.97M 5.00M 5.00M 4.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 5.40M 5.21M 5.12M 5.04M 5.06M 5.02M 4.93M 4.91M 4.92M 4.90M 4.94M
Normalized Net Operating Profit after Tax (NOPAT)		 13 7.04 16 18 27 24 29 35 56 65 37
Normalized NOPAT Margin		 3.29% 1.99% 4.65% 4.83% 6.38% 5.44% 6.32% 6.71% 8.79% 9.67% 6.25%
Pre Tax Income Margin		 5.52% 3.30% 6.22% 6.82% 7.74% 7.07% 8.70% 9.45% 11.57% 12.30% 8.55%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 32.80 21.03 25.48 24.92 25.89 14.84 17.82 25.09 23.74 21.62 22.70
NOPAT to Interest Expense		 19.39 12.46 18.53 12.07 20.82 10.92 12.31 17.17 15.93 16.58 16.70
EBIT Less CapEx to Interest Expense		 6.18 3.64 -3.73 14.46 18.65 1.57 11.96 16.07 12.09 13.25 17.66
NOPAT Less CapEx to Interest Expense		 -7.24 -4.93 -10.68 1.61 13.59 -2.35 6.45 8.15 4.28 8.20 11.66
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 34.31% 65.78% 27.34% 32.39% 15.38% 18.13% 14.06% 11.56% 7.54% 6.48% 10.98%
Augmented Payout Ratio		 51.68% 178.94% 60.57% 99.38% 31.05% 47.38% 45.85% 26.31% 17.58% 36.31% 34.17%

Quarterly Metrics And Ratios for Preformed Line Products

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 22.18% 29.27% 31.54% 11.22% -3.00% -14.31% -22.51% -23.70% -8.39% 14.78% 5.42%
EBITDA Growth		 19.58% 79.38% 89.45% 47.76% 14.58% -60.41% -48.92% -49.53% -36.21% 76.40% 11.32%
EBIT Growth		 27.52% 101.47% 99.40% 53.20% 9.98% -71.76% -60.05% -59.71% -47.97% 140.41% 16.76%
NOPAT Growth		 15.73% 104.21% 167.19% 50.86% 32.32% -62.45% -57.39% -54.69% -50.64% 67.91% 18.53%
Net Income Growth		 11.08% 84.22% 74.12% 49.14% 27.39% -61.74% -55.17% -54.23% -49.18% 65.56% 20.31%
EPS Growth		 9.77% 82.12% 71.89% 47.29% 28.39% -60.43% -54.67% -53.68% -49.17% 65.12% 20.10%
Operating Cash Flow Growth		 52.61% 79.05% 591.40% 2,137.92% 177.82% 13.25% -77.38% 38.56% -77.96% 24.78% -1.70%
Free Cash Flow Firm Growth		 -120.49% -94.59% 30.16% -33.85% 26.69% 86.21% 149.08% 207.32% 138.86% 651.10% 4.88%
Invested Capital Growth		 14.85% 21.04% 16.05% 16.95% 11.28% 3.36% -2.23% -8.40% -0.74% -7.31% -2.10%
Revenue Q/Q Growth		 1.18% 2.73% 7.00% -0.01% -11.76% -9.25% -3.23% -1.55% 5.95% 13.71% -11.12%
EBITDA Q/Q Growth		 -3.19% 44.81% 6.52% -1.05% -24.92% -49.96% 37.42% -2.23% -5.12% 38.38% -13.28%
EBIT Q/Q Growth		 -0.93% 36.91% 16.01% -2.64% -28.88% -64.84% 64.10% -1.82% -8.14% 62.44% -20.30%
NOPAT Q/Q Growth		 -15.33% 42.68% 31.14% -4.79% -25.73% -59.51% 48.82% 1.24% -19.09% 37.73% 5.06%
Net Income Q/Q Growth		 -13.35% 38.68% 29.91% -4.46% -25.99% -58.34% 52.21% -2.46% -17.84% 35.72% 10.61%
EPS Q/Q Growth		 -14.80% 38.14% 31.29% -4.67% -25.74% -57.43% 50.39% -2.58% -18.52% 38.31% 9.39%
Operating Cash Flow Q/Q Growth		 1,626.85% 11.32% 49.32% -19.70% 108.15% -54.62% -70.17% 391.81% -66.90% 156.96% -76.50%
Free Cash Flow Firm Q/Q Growth		 -16.30% -44.47% 28.58% -11.54% 36.30% 72.83% 354.24% 143.90% -76.93% 285.32% -51.61%
Invested Capital Q/Q Growth		 0.87% 7.16% 7.33% 0.81% -4.02% -0.47% 1.52% -5.55% 4.00% -7.06% 7.23%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 35.24% 36.62% 36.45% 36.48% 33.74% 33.04% 31.32% 31.92% 31.15% 33.29% 32.77%
EBITDA Margin		 13.05% 18.40% 18.31% 18.12% 15.42% 8.50% 12.07% 11.99% 10.74% 13.06% 12.75%
Operating Margin		 10.50% 14.47% 15.94% 15.48% 12.51% 4.77% 8.20% 8.14% 7.07% 10.48% 8.84%
EBIT Margin		 11.05% 14.72% 15.96% 15.54% 12.53% 4.85% 8.23% 8.21% 7.11% 10.16% 9.11%
Profit (Net Income) Margin		 7.19% 9.70% 11.78% 11.26% 9.44% 4.33% 6.82% 6.75% 5.24% 6.25% 7.78%
Tax Burden Percent		 67.57% 68.12% 75.80% 74.30% 77.37% 90.54% 80.98% 83.93% 73.79% 60.30% 84.51%
Interest Burden Percent		 96.30% 96.75% 97.37% 97.47% 97.41% 98.63% 102.28% 98.05% 99.75% 101.98% 100.99%
Effective Tax Rate		 32.43% 31.88% 24.20% 25.70% 22.63% 9.46% 19.02% 16.07% 26.21% 39.70% 15.49%
Return on Invested Capital (ROIC)		 11.81% 16.68% 19.96% 19.43% 16.53% 6.90% 9.55% 9.36% 7.00% 9.14% 10.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.18% 16.01% 19.00% 18.50% 15.59% 6.96% 10.15% 8.81% 7.23% 10.47% 23.78%
Return on Net Nonoperating Assets (RNNOA)		 1.52% 1.85% 3.06% 2.44% 1.75% 0.57% 1.03% 0.43% 0.21% -0.22% 0.19%
Return on Equity (ROE)		 13.33% 18.54% 23.02% 21.87% 18.28% 7.47% 10.58% 9.80% 7.21% 8.92% 10.69%
Cash Return on Invested Capital (CROIC)		 -2.01% -5.44% 0.76% 1.61% 7.81% 12.14% 14.18% 18.29% 8.43% 16.63% 11.21%
Operating Return on Assets (OROA)		 12.91% 17.74% 19.11% 18.75% 15.29% 5.55% 8.71% 8.05% 6.79% 10.25% 9.30%
Return on Assets (ROA)		 8.40% 11.69% 14.11% 13.58% 11.52% 4.95% 7.21% 6.62% 5.00% 6.31% 7.94%
Return on Common Equity (ROCE)		 13.33% 18.54% 23.02% 21.87% 18.28% 7.47% 10.58% 9.80% 7.21% 8.92% 10.69%
Return on Equity Simple (ROE_SIMPLE)		 14.16% 0.00% 16.68% 17.63% 18.39% 0.00% 12.46% 9.71% 7.69% 0.00% 8.96%
Net Operating Profit after Tax (NOPAT)		 12 17 22 21 16 6.29 9.36 9.48 7.67 11 11
NOPAT Margin		 7.10% 9.86% 12.08% 11.50% 9.68% 4.32% 6.64% 6.83% 5.22% 6.32% 7.47%
Net Nonoperating Expense Percent (NNEP)		 -0.38% 0.67% 0.96% 0.94% 0.95% -0.06% -0.60% 0.55% -0.23% -1.33% -13.28%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.74% - - - 1.31% - - - 2.34% 2.33%
Cost of Revenue to Revenue		 64.76% 63.38% 63.55% 63.52% 66.26% 66.96% 68.68% 68.08% 68.85% 66.71% 67.23%
SG&A Expenses to Revenue		 10.56% 11.53% 10.23% 10.02% 11.09% 13.75% 11.79% 10.99% 11.17% 11.49% 11.87%
R&D to Revenue		 2.87% 2.81% 2.86% 3.17% 3.64% 3.91% 3.85% 3.86% 3.77% 3.34% 3.69%
Operating Expenses to Revenue		 24.74% 22.15% 20.52% 21.00% 21.23% 28.26% 23.12% 23.78% 24.08% 22.81% 23.93%
Earnings before Interest and Taxes (EBIT)		 18 25 29 28 20 7.07 12 11 10 17 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 22 31 33 33 25 12 17 17 16 22 19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.05 1.13 1.64 1.93 1.99 1.56 1.52 1.47 1.46 1.48 1.59
Price to Tangible Book Value (P/TBV)		 1.19 1.28 1.85 2.16 2.21 1.74 1.69 1.62 1.61 1.62 1.74
Price to Revenue (P/Rev)		 0.58 0.63 0.92 1.10 1.14 0.97 1.00 1.04 1.10 1.05 1.15
Price to Earnings (P/E)		 7.42 7.43 9.85 10.93 10.80 10.26 12.21 15.13 19.06 16.85 17.72
Dividend Yield		 1.14% 0.97% 0.63% 0.52% 0.50% 0.60% 0.62% 0.64% 0.63% 0.63% 0.57%
Earnings Yield		 13.48% 13.47% 10.16% 9.15% 9.26% 9.74% 8.19% 6.61% 5.25% 5.94% 5.64%
Enterprise Value to Invested Capital (EV/IC)		 1.04 1.11 1.55 1.83 1.92 1.55 1.50 1.48 1.47 1.51 1.60
Enterprise Value to Revenue (EV/Rev)		 0.67 0.72 1.01 1.16 1.18 0.98 1.03 1.03 1.09 1.00 1.13
Enterprise Value to EBITDA (EV/EBITDA)		 5.07 4.92 6.33 6.84 6.72 6.37 7.43 8.52 10.08 8.37 9.26
Enterprise Value to EBIT (EV/EBIT)		 6.28 5.98 7.56 8.10 8.02 7.80 9.66 12.02 15.39 11.83 12.94
Enterprise Value to NOPAT (EV/NOPAT)		 9.41 8.91 10.67 11.41 10.93 10.17 12.41 14.81 19.00 16.07 17.44
Enterprise Value to Operating Cash Flow (EV/OCF)		 21.47 17.44 12.08 10.41 7.79 6.12 7.36 6.29 9.94 8.84 10.06
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 220.54 121.90 25.86 12.95 10.43 7.71 17.33 8.73 14.13
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.25 0.25 0.24 0.22 0.18 0.15 0.15 0.09 0.10 0.07 0.09
Long-Term Debt to Equity		 0.19 0.19 0.20 0.17 0.13 0.12 0.13 0.07 0.07 0.04 0.07
Financial Leverage		 0.12 0.12 0.16 0.13 0.11 0.08 0.10 0.05 0.03 -0.02 0.01
Leverage Ratio		 1.60 1.57 1.60 1.59 1.56 1.51 1.50 1.47 1.45 1.40 1.39
Compound Leverage Factor		 1.54 1.52 1.56 1.55 1.52 1.49 1.53 1.44 1.44 1.43 1.40
Debt to Total Capital		 20.12% 19.98% 19.52% 18.35% 15.03% 13.01% 13.39% 8.48% 8.96% 6.34% 8.67%
Short-Term Debt to Total Capital		 5.09% 4.71% 3.57% 4.22% 3.73% 2.81% 1.79% 2.14% 2.25% 2.26% 1.93%
Long-Term Debt to Total Capital		 15.03% 15.27% 15.96% 14.13% 11.30% 10.20% 11.59% 6.34% 6.70% 4.07% 6.73%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
Common Equity to Total Capital		 79.88% 80.02% 80.48% 81.65% 84.96% 86.99% 86.61% 91.52% 91.04% 93.66% 91.32%
Debt to EBITDA		 1.06 0.97 0.85 0.75 0.58 0.60 0.73 0.55 0.68 0.40 0.57
Net Debt to EBITDA		 0.66 0.56 0.56 0.39 0.22 0.08 0.21 -0.13 -0.09 -0.40 -0.18
Long-Term Debt to EBITDA		 0.79 0.74 0.70 0.58 0.44 0.47 0.64 0.41 0.51 0.26 0.44
Debt to NOPAT		 1.96 1.75 1.44 1.26 0.94 0.96 1.23 0.95 1.29 0.77 1.06
Net Debt to NOPAT		 1.23 1.02 0.94 0.65 0.36 0.13 0.35 -0.22 -0.16 -0.77 -0.35
Long-Term Debt to NOPAT		 1.47 1.34 1.17 0.97 0.71 0.75 1.06 0.71 0.96 0.49 0.83
Altman Z-Score		 3.89 4.01 4.53 4.90 5.15 4.87 5.03 5.17 5.04 5.39 5.52
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.56 2.85 2.71 2.79 2.49 2.92 3.15 2.93 2.81 2.91 3.08
Quick Ratio		 1.28 1.09 1.13 1.14 0.93 0.96 1.12 1.43 0.97 1.03 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -38 -55 -39 -44 -28 -7.57 19 47 11 42 20
Operating Cash Flow to CapEx		 134.60% 110.51% 309.10% 231.49% 561.92% 238.45% 844.79% 785.94% 271.79% 693.57% 51.95%
Free Cash Flow to Firm to Interest Expense		 -46.40 -50.61 -36.79 -38.57 -27.92 -10.71 27.18 82.64 19.20 109.50 53.69
Operating Cash Flow to Interest Expense		 18.68 15.70 23.86 18.01 42.59 27.28 8.13 49.81 16.61 63.17 15.04
Operating Cash Flow Less CapEx to Interest Expense		 4.80 1.49 16.14 10.23 35.01 15.84 7.16 43.48 10.50 54.06 -13.91
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.17 1.20 1.20 1.21 1.22 1.14 1.06 0.98 0.95 1.01 1.02
Accounts Receivable Turnover		 5.18 5.70 5.30 5.22 5.58 5.77 4.98 4.76 4.83 5.44 5.23
Inventory Turnover		 3.34 3.22 3.20 3.23 3.13 2.94 2.86 2.72 2.67 2.90 2.94
Fixed Asset Turnover		 3.89 3.92 3.86 3.91 3.85 3.50 3.15 2.92 2.84 2.95 2.96
Accounts Payable Turnover		 9.37 9.46 8.19 8.98 8.94 10.28 8.49 8.50 8.31 10.13 9.36
Days Sales Outstanding (DSO)		 70.42 64.02 68.88 69.90 65.47 63.27 73.33 76.67 75.56 67.10 69.81
Days Inventory Outstanding (DIO)		 109.38 113.33 114.15 112.93 116.56 124.35 127.77 134.11 136.84 125.94 124.03
Days Payable Outstanding (DPO)		 38.96 38.60 44.59 40.63 40.83 35.52 43.00 42.96 43.94 36.03 39.01
Cash Conversion Cycle (CCC)		 140.84 138.76 138.44 142.21 141.19 152.09 158.11 167.83 168.46 157.01 154.83
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 385 412 442 446 428 426 433 409 425 395 423
Invested Capital Turnover		 1.66 1.69 1.65 1.69 1.71 1.60 1.44 1.37 1.34 1.45 1.40
Increase / (Decrease) in Invested Capital		 50 72 61 65 43 14 -9.89 -37 -3.16 -31 -9.09
Enterprise Value (EV)		 400 456 686 814 821 659 647 603 623 596 678
Market Capitalization		 348 404 625 768 794 650 629 612 628 625 691
Book Value per Share		 $67.00 $72.90 $77.39 $80.52 $81.34 $85.04 $84.29 $84.63 $87.30 $86.23 $88.20
Tangible Book Value per Share		 $58.89 $64.34 $68.73 $71.79 $72.96 $76.36 $76.04 $76.71 $79.23 $78.81 $80.61
Total Capital		 414 448 473 488 471 478 477 455 471 451 477
Total Debt		 83 90 92 90 71 62 64 39 42 29 41
Total Long-Term Debt		 62 68 75 69 53 49 55 29 32 18 32
Net Debt		 52 52 61 46 27 8.64 18 -8.85 -5.30 -29 -13
Capital Expenditures (CapEx)		 11 15 8.23 8.82 7.56 8.09 0.68 3.60 3.45 3.47 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 178 197 199 204 176 173 177 163 170 160 175
Debt-free Net Working Capital (DFNWC)		 209 234 231 247 220 227 223 211 217 218 230
Net Working Capital (NWC)		 188 213 214 227 202 213 215 201 207 207 221
Net Nonoperating Expense (NNE)		 -0.15 0.26 0.55 0.45 0.39 -0.02 -0.24 0.11 -0.03 0.12 -0.46
Net Nonoperating Obligations (NNO)		 54 54 62 48 28 9.94 19 -7.63 -4.04 -27 -12
Total Depreciation and Amortization (D&A)		 3.31 6.24 4.28 4.69 4.64 5.31 5.41 5.25 5.32 4.85 5.40
Debt-free, Cash-free Net Working Capital to Revenue		 29.71% 30.88% 29.24% 29.20% 25.39% 25.88% 28.19% 27.90% 29.67% 27.01% 29.13%
Debt-free Net Working Capital to Revenue		 34.89% 36.73% 33.91% 35.37% 31.69% 33.89% 35.49% 36.00% 37.97% 36.65% 38.25%
Net Working Capital to Revenue		 31.36% 33.41% 31.43% 32.43% 29.16% 31.88% 34.12% 34.34% 36.11% 34.93% 36.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.41 $3.35 $4.33 $4.14 $3.08 $1.32 $1.95 $1.91 $1.57 $2.13 $2.34
Adjusted Weighted Average Basic Shares Outstanding		 4.94M 4.93M 4.94M 4.94M 4.91M 4.92M 4.92M 4.92M 4.90M 4.91M 4.93M
Adjusted Diluted Earnings per Share		 $2.36 $3.26 $4.28 $4.08 $3.03 $1.29 $1.94 $1.89 $1.54 $2.13 $2.33
Adjusted Weighted Average Diluted Shares Outstanding		 5.04M 5.00M 5.00M 5.02M 4.99M 5.00M 4.94M 4.96M 4.98M 4.95M 4.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 4.92M 4.92M 4.95M 4.92M 4.89M 4.90M 4.92M 4.91M 4.90M 4.94M 4.94M
Normalized Net Operating Profit after Tax (NOPAT)		 16 17 22 21 16 6.29 9.36 9.48 7.67 11 11
Normalized NOPAT Margin		 9.76% 9.86% 12.08% 11.50% 9.68% 4.32% 6.64% 6.83% 5.22% 6.32% 7.47%
Pre Tax Income Margin		 10.64% 14.24% 15.54% 15.15% 12.20% 4.79% 8.42% 8.05% 7.10% 10.36% 9.20%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 22.31 23.06 27.22 24.92 20.14 9.99 16.38 20.04 18.54 44.58 36.00
NOPAT to Interest Expense		 14.33 15.44 20.61 18.44 15.56 8.90 13.22 16.68 13.60 27.72 29.51
EBIT Less CapEx to Interest Expense		 8.43 8.85 19.51 17.14 12.56 -1.45 15.41 13.70 12.43 35.47 7.05
NOPAT Less CapEx to Interest Expense		 0.46 1.23 12.89 10.66 7.99 -2.54 12.26 10.35 7.49 18.61 0.56
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 8.79% 7.54% 6.65% 5.95% 5.63% 6.48% 7.92% 10.09% 12.36% 10.98% 10.52%
Augmented Payout Ratio		 17.19% 17.58% 18.32% 25.18% 32.74% 36.31% 47.91% 47.37% 38.89% 34.17% 30.91%

Key Financial Trends

Preformed Line Products reported solid profitability in Q1 2025, with earnings and margins expanding year-over-year despite some cyclical softness in revenue. The company generated positive free cash flow and maintained a strong balance sheet with low net debt leverage. Key financial ratios remain healthy, though top-line comparisons to Q4 2024 show typical seasonal declines.

  • Net Income grew 10.6% quarter-over-quarter, driven by higher margins and cost control.
  • Adjusted EPS rose to $2.34, up 20.1% year-over-year.
  • NOPAT increased 18.5% versus Q1 2024, with NOPAT margin expanding to 7.47%.
  • EBITDA reached $18.9 million, an 11.3% increase over the prior year.
  • Free Cash Flow to Firm was $20.2 million, supporting dividends and share repurchases.
  • Net debt to EBITDA is negative (-0.18x), reflecting a net cash position and low leverage.
  • Return on Invested Capital (ROIC) improved to 10.5%, surpassing the company’s WACC.
  • Revenue declined 11.1% Q/Q, reflecting normal seasonality in industrial end markets.
  • CapEx of $10.9 million offset some operating cash flow, keeping OCF to CapEx at 52%.
  • Operating Cash Flow fell 1.7% from Q1 2024, indicating working capital absorption.
06/20/25 04:47 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Preformed Line Products' Financials

When does Preformed Line Products' fiscal year end?

According to the most recent income statement we have on file, Preformed Line Products' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Preformed Line Products' net income changed over the last 10 years?

Preformed Line Products' net income appears to be on an upward trend, with a most recent value of $37.11 million in 2024, rising from $12.86 million in 2014. The previous period was $63.34 million in 2023.

What is Preformed Line Products' operating income?
Preformed Line Products' total operating income in 2024 was $50.76 million, based on the following breakdown:
  • Total Gross Profit: $189.81 million
  • Total Operating Expenses: $139.05 million
How has Preformed Line Products' revenue changed over the last 10 years?

Over the last 10 years, Preformed Line Products' total revenue changed from $388.19 million in 2014 to $593.71 million in 2024, a change of 52.9%.

How much debt does Preformed Line Products have?

Preformed Line Products' total liabilities were at $151.55 million at the end of 2024, a 19.0% decrease from 2023, and a 36.5% increase since 2014.

How has Preformed Line Products' book value per share changed over the last 10 years?

Over the last 10 years, Preformed Line Products' book value per share changed from 45.37 in 2014 to 86.23 in 2024, a change of 90.1%.


Related Companies

This page (NASDAQ:PLPC) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
The Biggest Story of My Decade-Long Career in Silicon Valley
Steve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...
InvestorPlace | Sponsored
379 passengers walked away from this
Elon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...
True Market Insiders | Sponsored
A grave, grave error.
It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...
Porter & Company | Sponsored